Unituxin Interactions
There are 292 drugs known to interact with Unituxin (dinutuximab), along with 6 disease interactions. Of the total drug interactions, 70 are major, and 222 are moderate.
- View all 292 medications that may interact with Unituxin
- View Unituxin disease interactions (6)
Most frequently checked interactions
View interaction reports for Unituxin (dinutuximab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- amlodipine
- ampicillin / sulbactam
- Arava (leflunomide)
- Arcapta (indacaterol)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- axicabtagene ciloleucel
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- belantamab mafodotin
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- chloramphenicol ophthalmic
- clonidine
- Copaxone (glatiramer)
- Corlanor (ivabradine)
Unituxin disease interactions
There are 6 disease interactions with Unituxin (dinutuximab) which include:
- electrolytes abnormalities
- hemolytic uremic syndrome
- hypotension
- myelosuppression
- neurotoxicity
- posterior leukoencephalopathy syndrome
Report options
More about Unituxin (dinutuximab)
- Unituxin consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Oncovin
Oncovin is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Danyelza
Danyelza (naxitamab-gqgk) is a GD2-binding monoclonal antibody used for the treatment of patients ...
Vincristine
Vincristine is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.